SOUTH SAN FRANCISCO, Calif., June 11, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer of Five Prime, will present at the 2014 Wells Fargo Healthcare Conference on Wednesday, June 18 at 1:50 PM Eastern Time.

The live webcast will be accessible at http://investor.fiveprime.com/events.cfm or as a direct feed from http://cc.talkpoint.com/well001/061714a_ac/?e...53_LH1SNFW . Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime

Five Prime is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,700 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets for protein therapeutics. Additional information can be found at the company's website: www.fiveprime.com .

COMPANY CONTACT: Amy Kendall Corporate Communications 415-365-5776